Literature DB >> 20472998

Membrane materials for blood purification in critical care.

Akihiro C Yamashita, Narumi Tomisawa.   

Abstract

Since therapeutic conditions, especially the amount of dialysate, are usually limited in continuous renal replacement therapy (CRRT), selecting an appropriate membrane is more crucial than that in chronic hemodialysis. Under such circumstances, the use of a membrane with adsorption is expected to remove a larger amount of target substances in CRRT. Five commercial dialyzers were investigated to demonstrate the importance of membrane characteristics. The adsorptive characteristics of polymethylmethacrylate (PMMA) membrane were relatively low for cytochrome c (MW 12,400), very strong for alpha-chymotrypsinogen A (MW 25,000) and relatively strong for albumin (MW 66,000), which may be understood that the adsorption in PMMA has the optimal molecular size. On the other hand, polyacrylonitrile showed relatively low affinity and polysulfone showed essentially no affinity to these protein molecules. Time- and concentration-dependent characteristics of clearance for these proteins were also demonstrated in PMMA. Then we concluded that adsorption found in PMMA may be due to the occlusion of protein molecules into pores of entirely dense membrane. Selecting membrane materials is, therefore, important not only in removing inflammatory cytokines but also in considering the loss of albumin in clinical treatments because even albumin can be adsorbed by the membrane used in blood purification therapies. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472998     DOI: 10.1159/000314859

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  1 in total

1.  Clinical efficacy of blood purification using a polymethylmethacrylate hemofilter for the treatment of severe acute pancreatitis.

Authors:  Kiyohiko Kinjoh; Ryoji Nagamura; Yutaka Sakuda; Shoki Yamauchi; Hideta Takushi; Tadashi Iraha; Koji Idomari
Journal:  Acute Crit Care       Date:  2022-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.